UPDATE: Threshold Pharma (THLD) Receives Orphan Drug Status for TH-302 for the Treatment of Soft Tissue Sarcoma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. JPM
2. BAC
3. SPY
4. WFC
5. ERAS
6. IBM
7. SPRO
8. TREX
9. AAPL
10. ORCL

Go back to UPDATE: Threshold Pharma (THLD) Receives Orphan Drug Status for TH-302 for the Treatment of Soft Tissue Sarcoma